You might have read and heard a lot of neurological conditions like Alzheimer’s and Parkinson’s, however, there’s another ...

While dementia and Alzheimer’s disease are terms that are often used interchangeably, they don’t mean the same thing. Understanding the difference isn’t just helpful for clarity, it’s ...

Health Alzheimer's disease could be prevented by antiviral drug already on market Researchers discover that HIV medication may prevent up to 60,000 US Alzheimer's cases yearly By Melissa Rudy Fox News ...

Omega-3 fatty acids, huperzine A, and synthetic coenzyme Q10 have been proven in clinical trials to be no better than placebo (i.e., like a sugar pill) for Alzheimer's disease patients, according ...

The Alzheimer’s Association has launched a new, free app to help those in the early stages of the disease and their loved ...

While Alzheimer’s is a specific disease and the most common cause of dementia, dementia is a broader, "umbrella term that describes a collection of cognitive, functional and behavioral symptoms ...

Disproven alternative therapies for treating cognitive symptoms in Alzheimer's disease include omega-3 fatty acids, huperzine A, and synthetic coenzyme Q10, according to the Alzheimer's Association.

Alzheimer’s disease now affects more than seven million people in the U.S., and nearly four in five Americans say they would want to know if they have it before symptoms emerge. This data comes ...

Identifying common disease trajectories of Alzheimer’s disease with electronic health records. eBioMedicine, 2025; 118: 105831 DOI: 10.1016/j.ebiom.2025.105831 ...

With the number of Americans living with the disease steadily increasing, scientists predict that 13.8 million will have Alzheimer’s by 2050, or 16% of the US population over the age of 65.

A cholinergic agonist first developed in the 1990s for Alzheimer’s disease, xanomeline, was approved last year in combination with trospium chloride, a side-effect blocker, for the treatment of ...